Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Helen M. Colhoun
Based on 13 articles published since 2008
||||
Expertise Level
The expertise of Helen M. Colhoun ranks in the
  • Top 0.22%
  • ... of 27,988 published authors worldwide on Hypercholesterolemia
  • ... from 2008 through 2018
  • ... based on contributions to 13 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Colhoun, H M   ·   Colhoun, Helen M
Work Locations
Details
Most likely:    University of Edinburgh      
2017
  • Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. · Department of Endocrinology, l'institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, Nantes, France. · Department of Internal Medicine I, University Hospital RWTH Aachen, Aachen, Germany. · University of Edinburgh, Edinburgh, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Hospital Virgen de la Victoria, CIBERobn, Málaga University, Málaga, Spain. · Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK. · Sanofi, Paris, France. · Sanofi, Gentilly, France. · Sanofi, Chilly-Mazarin, France. · IviData Stats, Levallois-Perret, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · University of California San Diego School of Medicine, and Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, California. · Pubmed 28905478
  • Cardiovascular Center of Sarasota, Sarasota, Florida. Electronic address: · Harvard Clinical Research Institute, Boston, Massachusetts. · Division of Lipidology, Department of Medicine, University of Cape Town and MRC Cape Heart Group, Cape Town, South Africa. · Virginia Commonwealth University and National Clinical Research, Inc., Richmond, Virginia. · L'Institut du Thorax, CHU de Nantes, Nantes, France. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · Sanofi, Bridgewater, New Jersey. · University of Edinburgh, Edinburgh, UK. · Pubmed 28750828
  • Lipid Clinic, Point Médical, Dijon, France; Department of Cardiology, CHU Dijon Bourgogne, Dijon, France. Electronic address: · University of Edinburgh, Edinburgh, UK. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Sanofi, Bridgewater, NJ, USA. · Sanofi, Chilly-Mazarin, France. · University of Iowa, Iowa City, IA, USA. · Pubmed 28693998
  • Institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, 44093 Nantes cedex 1, France. Electronic address: · Li KaShing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. · Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany. · IVIDATA, 92300 Levallois-Perret, France. · University of Edinburgh, Edinburgh, Scotland, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · University of California San Diego School of Medicine, Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, CA, USA. · CIBERobn, Hospital Virgen de la Victoria, Málaga University, Spain. · Sanofi, 91380 Chilly-Mazarin, France. · Sanofi, Bridgewater, NJ, USA. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Department of Primary Care and Public Health, School of Public Health, Imperial College, London, UK. · Sanofi, 75008 Paris, France. · Pubmed 28347654
  • Louisville Metabolic and Atherosclerosis Research Center (L-MARC), Louisville, KY · University of Toronto, Ontario, Canada. · Western General Hospital, Edinburgh, UK. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY. · Sanofi, Paris, France. · CGH Medical Center, Sterling, IL. · Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD. · Pubmed 28862926
2016
  • University of Edinburgh, Edinburgh, UK · Columbia University, New York, NY, USA. · University of Iowa, Iowa City, IA, USA. · Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. · University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen University, Aachen, Germany. · University of California San Diego School of Medicine, La Jolla, CA, USA. · Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, CA, USA. · CHU Nantes, Institut du Thorax, France. · Sanofi, Montpellier, France. · Regeneron Pharmaceuticals, Tarrytown, NY, USA. · Sanofi, Paris, France. · University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. · Pubmed 27460890
Probable:    University of Dundee      
2016
  • Point Médical, Dijon, France. Electronic address: · Baylor College of Medicine, Houston, TX, USA. · Radiant Research - Phoenix SE, Chandler, AZ, USA. · Università di Palermo - Policlinico "P. Giaccone", Palermo, Italy. · Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany. · University of Dundee, Dundee, Scotland. · Regeneron Pharmaceuticals, Inc. Tarrytown, NY, USA. · Sanofi, Paris, France. · Pubmed 26638010
2015
  • The Christ Hospital, Heart and Vascular Center/The Lindner Research Center, Cincinnati, OH. Electronic address: · University of Iowa, Iowa City, IA. · Harvard Clinical Research Institute, Boston, MA. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc, Tarrytown, NY. · Sanofi, Bridgewater, NJ. · University of Dundee, Dundee, Scotland, United Kingdom. · Pubmed 26027630
  • Harvard Clinical Research Institute, 930 W. Commonwealth Ave, Boston, MA 02215, USA · Department of Endocrinology, L'Institut du Thorax, CHU de Nantes, Nantes, France. · Division of Lipidology, Department of Medicine, University of Cape Town and MRC Cape Heart Group, Cape Town, South Africa. · Virginia Commonwealth University and National Clinical Research, Inc., Richmond, VA, USA. · Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Sanofi, Bridgewater, NJ, USA. · University of Dundee, Dundee, UK. · Pubmed 25687353
2014
  • University of Dundee, Dundee, Scotland DD2 4BF, UK. · Pubmed 25240705
  • The Sterling Research Group, Cincinnati, OH, USA. Electronic address: · Cardiovascular Research Unit, Diabetes and Obesity Research Program, University of Helsinki, Finland. · Columbia University, New York, NY, USA. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Medical Research Institute, University of Dundee, Dundee, UK. · College of Public Health, University of Iowa, IA, USA. · Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Sanofi, Montpellier, France. · Pubmed 25037695
Possible:    University of Iowa   Contact    
2014
  • Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City, Iowa. · Pubmed 25269777
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 13 total) written by Helen M. Colhoun about Hypercholesterolemia:

  • Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM-INSULIN randomized trial. 2017
  • Efficacy and Safety of Alirocumab Versus Ezetimibe Over 2 Years (from ODYSSEY COMBO II). 2017
  • Long-term treatment adherence to the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab in 6 ODYSSEY Phase III clinical studies with treatment duration of 1 to 2 years. 2017
  • Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM-INSULIN trial. 2017
  • Alirocumab Treatment and Achievement of Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B Goals in Patients With Hypercholesterolemia: Pooled Results From 10 Phase 3 ODYSSEY Trials. 2017
  • No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies. 2016
  • Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial. 2016
  • Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study. 2015
  • Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial. 2015
  • Efficacy and safety of alirocumab as add-on therapy in high-cardiovascular-risk patients with hypercholesterolemia not adequately controlled with atorvastatin (20 or 40 mg) or rosuvastatin (10 or 20 mg): design and rationale of the ODYSSEY OPTIONS Studies. 2014
Show List of Full Article Records
Google Searches

Learn more about Helen M. Colhoun using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Edinburgh
University of Dundee
University of Iowa
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Edinburgh
2017
  • Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. · Department of Endocrinology, l'institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, Nantes, France. · Department of Internal Medicine I, University Hospital RWTH Aachen, Aachen, Germany. · University of Edinburgh, Edinburgh, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Hospital Virgen de la Victoria, CIBERobn, Málaga University, Málaga, Spain. · Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK. · Sanofi, Paris, France. · Sanofi, Gentilly, France. · Sanofi, Chilly-Mazarin, France. · IviData Stats, Levallois-Perret, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · University of California San Diego School of Medicine, and Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, California. · Pubmed 28905478
  • Cardiovascular Center of Sarasota, Sarasota, Florida. Electronic address: · Harvard Clinical Research Institute, Boston, Massachusetts. · Division of Lipidology, Department of Medicine, University of Cape Town and MRC Cape Heart Group, Cape Town, South Africa. · Virginia Commonwealth University and National Clinical Research, Inc., Richmond, Virginia. · L'Institut du Thorax, CHU de Nantes, Nantes, France. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · Sanofi, Bridgewater, New Jersey. · University of Edinburgh, Edinburgh, UK. · Pubmed 28750828
  • Lipid Clinic, Point Médical, Dijon, France; Department of Cardiology, CHU Dijon Bourgogne, Dijon, France. Electronic address: · University of Edinburgh, Edinburgh, UK. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Sanofi, Bridgewater, NJ, USA. · Sanofi, Chilly-Mazarin, France. · University of Iowa, Iowa City, IA, USA. · Pubmed 28693998
  • Institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, 44093 Nantes cedex 1, France. Electronic address: · Li KaShing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. · Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany. · IVIDATA, 92300 Levallois-Perret, France. · University of Edinburgh, Edinburgh, Scotland, UK. · Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · University of California San Diego School of Medicine, Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, CA, USA. · CIBERobn, Hospital Virgen de la Victoria, Málaga University, Spain. · Sanofi, 91380 Chilly-Mazarin, France. · Sanofi, Bridgewater, NJ, USA. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Department of Primary Care and Public Health, School of Public Health, Imperial College, London, UK. · Sanofi, 75008 Paris, France. · Pubmed 28347654
  • Louisville Metabolic and Atherosclerosis Research Center (L-MARC), Louisville, KY · University of Toronto, Ontario, Canada. · Western General Hospital, Edinburgh, UK. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY. · Sanofi, Paris, France. · CGH Medical Center, Sterling, IL. · Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD. · Pubmed 28862926
2016
  • University of Edinburgh, Edinburgh, UK · Columbia University, New York, NY, USA. · University of Iowa, Iowa City, IA, USA. · Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. · University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen University, Aachen, Germany. · University of California San Diego School of Medicine, La Jolla, CA, USA. · Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, CA, USA. · CHU Nantes, Institut du Thorax, France. · Sanofi, Montpellier, France. · Regeneron Pharmaceuticals, Tarrytown, NY, USA. · Sanofi, Paris, France. · University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. · Pubmed 27460890
University of Dundee
2016
  • Point Médical, Dijon, France. Electronic address: · Baylor College of Medicine, Houston, TX, USA. · Radiant Research - Phoenix SE, Chandler, AZ, USA. · Università di Palermo - Policlinico "P. Giaccone", Palermo, Italy. · Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany. · University of Dundee, Dundee, Scotland. · Regeneron Pharmaceuticals, Inc. Tarrytown, NY, USA. · Sanofi, Paris, France. · Pubmed 26638010
2015
  • The Christ Hospital, Heart and Vascular Center/The Lindner Research Center, Cincinnati, OH. Electronic address: · University of Iowa, Iowa City, IA. · Harvard Clinical Research Institute, Boston, MA. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc, Tarrytown, NY. · Sanofi, Bridgewater, NJ. · University of Dundee, Dundee, Scotland, United Kingdom. · Pubmed 26027630
  • Harvard Clinical Research Institute, 930 W. Commonwealth Ave, Boston, MA 02215, USA · Department of Endocrinology, L'Institut du Thorax, CHU de Nantes, Nantes, France. · Division of Lipidology, Department of Medicine, University of Cape Town and MRC Cape Heart Group, Cape Town, South Africa. · Virginia Commonwealth University and National Clinical Research, Inc., Richmond, VA, USA. · Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Sanofi, Bridgewater, NJ, USA. · University of Dundee, Dundee, UK. · Pubmed 25687353
2014
  • University of Dundee, Dundee, Scotland DD2 4BF, UK. · Pubmed 25240705
  • The Sterling Research Group, Cincinnati, OH, USA. Electronic address: · Cardiovascular Research Unit, Diabetes and Obesity Research Program, University of Helsinki, Finland. · Columbia University, New York, NY, USA. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Medical Research Institute, University of Dundee, Dundee, UK. · College of Public Health, University of Iowa, IA, USA. · Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Sanofi, Montpellier, France. · Pubmed 25037695
University of Iowa
2014
  • Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City, Iowa. · Pubmed 25269777
University of Amsterdam
2012
  • Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 22453571
Yearly article counts 05223010000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.